3-methoxy-4-hydroxymandelic acid

03/01/1980 - "Studies in 20 patients, and a reanalysis of previously published data demonstrate that there is a significant linear relationship between the rate of urinary excretion of 3-methoxy-4-hydroxymandelic acid and the size of a pheochromocytoma. "
09/03/1960 - "[Experiences with Studnitz' and Hanson's method for the determination of 3-methoxy-4-hydroxymandelic acid in urine and its value for the diagnosis of pheochromocytoma]."
01/01/1960 - "The diagnosis of pheochromocytoma by determination of urinary 3-methoxy-4-hydroxymandelic acid."
12/01/1960 - "[The significance of 3-methoxy-4-hydroxymandelic acid (VMS) for the diagnosis of pheochromocytoma and for a study of catecholamine metabolism]."
03/01/1961 - "Excretion of 3-methoxy-4-hydroxymandelic acid and catecholamines in patients with pheochromocytoma."

06/01/1965 - "[Study of 3-methoxy-4-hydroxymandelic acid in endogenous psychoses]."

08/01/1975 - "Since elevation of 3-methoxy-4-hydroxymandelic acid (VMA) excretion frequently occurs in patients with neuroblastoma, simpler methods have been developed to differentiate between high and low levels of VMA in the urine, namely the LaBrosse spot test and VMA test strips. "
09/01/1962 - "Urinary excretion of 3-methoxy-4-hydroxymandelic acid in children with neuroblastoma."
05/01/1987 - "Eighty-two serum samples from 19 patients with neuroblastoma all showed NSE values (mean 120.2 ng/mL, range 16.2 to 722.0 ng/mL) elevated beyond the upper border of the normal range (14.6 ng/mL), even though four of the 19 patients had normal urinary excretion of 3-methoxy-4-hydroxymandelic acid (VMA) and 3-methoxy-4-hydroxy-phenylacetic acid (HVA). "
06/01/1980 - "Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors."
03/01/1961 - "Urinary excretion of norepinephrine, epinephrine and 3-methoxy-4-hydroxymandelic acid by children with neuroblastoma."

06/01/1980 - "Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors."
02/01/1994 - "Normal values for 3-methoxy-4-hydroxymandelic acid (VMA) were found in two patients with pure epinephrine-secreting tumors and in one patient with multiple endocrine neoplasia type II. Plasma catecholamines were usually less increased than their urinary counterparts. "
12/07/1962 - "[Isolation of 3-methoxy-4-hydroxymandelic acid (vanillin-mandelic acid) and 3-methoxy-4-hydroxphenylacetic acid (homovanillic acid) in tumors of the sympathoadrenal system]."

05/01/1962 - "[Urinary 3-methoxy-4-hydroxymandelic acid in the appraisal of arterial hypertension]."
04/01/1975 - "He received treatment for hypertension and showed slightly increased excretion of 17-OHCS- and 17-ketosteroids but no increase in values for 3-methoxy-4-hydroxymandelic acid in the urine. "
01/01/1984 - "We have assessed the elimination rate of 22Na (ER-22Na), total exchangeable sodium (NaE), blood pressure, plasma volume (PV), haematocrit, urinary noradrenaline (U-NA) and urinary 3-methoxy-4-hydroxymandelic acid (U-VMA) in normotensive men with (n = 17) and without (n = 15) familial predisposition to hypertension. "